9 completed, 2 terminated, 2 unknown, 1 withdrawn. 6 Not applicable, 3 Phase 4, 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Terminated 2, Unknown 1 |
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow gadofosveset trisodium: new trials by email Literature Review of gadofosveset trisodium trials Research Report on gadofosveset trisodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease ferumoxytol, gadofosveset - Pediatric Congenital Heart Disease | Phase 4 | Completed | Paul Finn | 17 | 2016-04-01 | 2022-12-28 |
| Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer Gadofosveset trisodium (Ablavar™ ), MRI - Ovarian Neoplasms | Phase 4 | Withdrawn | Maastricht University Medical Center | 2014-09-01 | 2015-09-28 | |
| Gadofosveset Trisodium (Ablavar, Gdfos) in Distinguishing Hemangiomas and Metastases: A Prospective Trial Liver MRI with Gdfos, Liver MRI with EcGd - Cancer, Metastases | Not applicable | Unknown | Sunnybrook Health Sciences Centre | 150 | 2013-08-01 | 2014-01-14 |
| Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer GADOFOSVESET TRISODIUM 244 Mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Ablavar] - Rectal Neoplasms, Magnetic Resonance Imaging | Completed | Maastricht University Medical Center | 307 | 2012-10-01 | 2017-03-22 | |
| Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods MRI with gadofosveset and MR elastography - Prostate Cancer | Not applicable | Terminated | Sunnybrook Health Sciences Centre | 5 | 2012-09-01 | 2016-10-18 |
| Nodal Staging in Breast Cancer With MRL Gadofosveset enhanced MRL of axillary lymph nodes - Breast Neoplasms | Not applicable | Terminated | Maastricht University Medical Center | 97 | 2012-05-01 | 2016-11-10 |
| Gadofosveset for Axillary Staging in Breast Cancer Patients Gadofosveset contrast agent enhanced MRI Axilla - Breast Neoplasms | Not applicable | Completed | Maastricht University Medical Center | 10 | 2011-09-01 | 2012-04-06 |
| Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants gadofosveset - Healthy | Not applicable | Completed | Duke University | 30 | 2011-08-01 | 2013-12-10 |
| Imaging of Totally Blocked Arteries MS-325 Injection (Gadofosveset Trisodium) - Atherosclerosis, Peripheral Artery Disease | Phase 1 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 20 | 2007-04-05 | 2017-07-02 |
| Detection of Coronary Vulnerable Plaque With Contrast-enhanced Magnetic Resonance Imaging Contrast enhanced MRI with Gadofosveset - Coronary Artery Disease, Stable Angina | Not applicable | Completed | Maastricht University Medical Center | 20 | 2007-03-01 | 2009-09-25 |
| Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist Vasovist - Congenital Heart Disease | Phase 4 | Unknown | Guy's Hospital | 2007-03-01 | 2009-08-03 | |
| Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent Multihance, vasovist - Steno-occlusive Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 39 | 2006-12-01 | 2023-08-01 |
| Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease Vasovist (BAY86-5283, MS-325) - Peripheral Vascular Diseases | Phase 3 | Completed | Bayer | 261 | 2006-02-01 | 2010-04-23 |
| Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases Bone scan, 99mTc-methyl diphosphonate, Positron Emission Tomography (PET) scan - Cancer | Phase 2 | Completed | Stanford University | 114 | 2006-01-01 | 2023-12-12 |
Breast Neoplasms (2) · Lymphatic Metastasis (2) · Neoplasms (2) · Peripheral Arterial Disease (2) · Angina, Stable (1) · Angina, Unstable (1) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Heart Defects, Congenital (1) · Intermittent Claudication (1) · Liver Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Peripheral Vascular Diseases (1)
Maastricht University Medical Center (5) · Sunnybrook Health Sciences Centre (2) · Bayer (1) · Bracco Diagnostics, Inc (1) · Duke University (1) · Guy's Hospital (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Paul Finn (1) · Stanford University (1)
Netherlands (5) · United States (4) · Canada (2) · Argentina (1) · Austria (1) · Brazil (1) · Germany (1) · Italy (1) · Mexico (1) · Switzerland (1) · United Kingdom (1)
Andrei Iagaru, MD (1) · Charles Y Kim, MD (1) · Doenja Lambregts, MD (1) · Geerard Beets, Ass Prof. MD (1) · Gianpaolo Pirovano, MD (1) · Laurent Milot, MD (1) · Masoom A Haider, M.D. (1) · Monique Maas, MD (1) · Regina Beets-Tan, Prof. MD. (1) · Tim Leiner, MD, PhD (1) · Toon Van Gorp, Dr (1)
PMID 22782568, PMID 23455520, PMID 24045249, PMID 26405167, PMID 26956325, PMID 31236756